Period Ending | Mar 30, 2013 | Mar 30, 2012 | Mar 30, 2011 |
---|
Total Revenue
|
122,455,000
|
122,734,000
|
112,084,000
| Cost of Revenue | 115,471,000 | 116,167,000 | 106,114,000 | |
Gross Profit
|
6,984,000
|
6,567,000
|
5,970,000
| |
|
Operating Expenses |
|
Research Development | 480,000 | 440,000 | 407,000 |
|
Selling General and Administrative | 4,198,000 | 3,829,000 | 3,529,000 |
|
Non Recurring | 72,000 | 149,000 | 213,000 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
2,315,000
|
2,149,000
|
1,821,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 116,000 | 21,000 | 36,000 |
|
Earnings Before Interest And Taxes | 2,159,000 | 2,170,000 | 1,857,000 |
|
Interest Expense | 240,000 | 251,000 | 222,000 |
|
Income Before Tax | 1,919,000 | 1,919,000 | 1,635,000 |
|
Income Tax Expense | 581,000 | 516,000 | 505,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,338,000 | 1,403,000 | 1,130,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
| 72,000 |
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
1,338,000
|
1,403,000
|
1,202,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,338,000
|
1,403,000
|
1,202,000
|
|